> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Voluntary Improvement Program Guidance
- URL: https://www.fdaweb.com/voluntary-improvement-program-guidance/
- Published: 2023-09-14T12:00:00.000Z
- Updated: 2026-09-14T18:56:39.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155326

FDA has published a guidance, *Fostering Medical Device Improvement: FDA Activities and Engagement with the Voluntary Improvement Program*, to describe agency policy in participating in the program. The document says the Voluntary Improvement Program (VIP) is a voluntary program facilitated through the Medical Device Innovation Consortium that evaluates the capability and performance of a medical device manufacturer’s practices using third-party appraisals. It is intended to guide improvement to enhance the quality of devices.

FDA says the VIP builds on the framework piloted through the agency’s 2018 Case for Voluntary Medical Device Manufacturing and Product Quality Pilot Program and incorporates some of the successes and learnings from the pilot.

The guidance contains an Introduction, Background, Program Features, Voluntary Improvement Program Operations, FDA Activities and Engagement with VIP, Paperwork Reduction Act of 1995, and two Appendices.